Disease/Infection News

RSS

Vitamin C and COVID-19: A Review

In a recent review published in Preprints*, Patrick Holford et al. address vitamin C's role as adjunctive therapy for respiratory infection, sepsis, and COVID-19.

23 Oct 2020

Seropositivity to SARS-CoV-2 among asymptomatic blood donors in New York

New York was the hardest-hit U.S. state during the peak of the outbreak in the country. Now, a team of researchers from the New York Blood Center and Serimmune, an immune intelligence company, aimed to determine the prevalence of seropositive people for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, among healthy blood donors.

23 Oct 2020

Biomimetic virus-like particles for safer positive controls in SARS-CoV-2 detection

In an attempt to overcome these issues, a team of researchers from various departments at the University of California San Diego recently proposed using biomimetic virus-like particles (VLPs) as positive controls for assays used in SARS-CoV-2 detection. Their study is published on the preprint server bioRxiv.

23 Oct 2020

Study raises new questions about viral load in asymptomatic children with COVID-19

New questions are at the forefront as a study published in the Journal of Clinical Microbiology from nine children's hospitals finds that most asymptomatic children who tested positive for COVID-19 had relatively low levels of the virus compared to symptomatic children.

22 Oct 2020

Meaning in life and self-control protect against stress during COVID-19 pandemic

Numerous studies over the last few weeks have pointed out that the effects of the Corona pandemic on people's mental health can be enormous and affect large parts of the population.

22 Oct 2020

Navy researchers evaluate commercial UV sources for viral disinfection to combat COVID-19

U.S. Naval Research Laboratory researchers evaluated commercial ultraviolet (UV) sources for viral disinfection to combat COVID-19 on land and at sea, and established a dedicated UV characterization lab in five days to ensure safe introduction and effective operation of UV sources across the Fleet.

22 Oct 2020

Nutritional status may impact susceptibility to COVID-19, study says

Now, a team of researchers at the London School of Hygiene & Tropical Medicine and the University of Oxford wanted to provide a systematic review of the latest evidence on how malnutrition across all forms, including undernutrition, obesity, and micronutrient status, may influence the susceptibility and severity of COVID-19.

22 Oct 2020

Anxiety and stress caused by COVID-19 associated with body image issues

A new study has found that anxiety and stress directly linked to COVID-19 could be causing a number of body image issues amongst women and men.

22 Oct 2020

Initial lockdown in France substantially curbed COVID-19, but many remain susceptible to the virus

Now, a new study by researchers at the Santé Publique France conducted seroprevalence estimates in France, one of the countries with high COVID-19 cases in Europe.

22 Oct 2020

WHO and Wikimedia Foundation expand public's access to most reliable information about COVID-19

The World Health Organization and the Wikimedia Foundation, the nonprofit that administers Wikipedia, announced today a collaboration to expand the public's access to the latest and most reliable information about COVID-19.

22 Oct 2020

DNA vaccine-induced antibodies neutralize SARS-CoV-2

The coronavirus disease (COVID-19) is far from over as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage across the globe. With the vast spread of the virus, many countries who reported flattening the curve over the past months have reported clusters of new cases and second waves of the outbreak.

22 Oct 2020

$2 million NCI SeroNet grant aims to increase diversity in COVID-19 immunology research

A new, $2 million grant from the NCI Serological Sciences Network for COVID-19 (SeroNet) is aimed at enhancing representation of Black and Hispanic people in SARS-CoV-2 immunology research through the use of storytelling--an approach in which community members become "video stars" and provide honest messages about the importance of being represented in COVID-19 research studies.

22 Oct 2020

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

22 Oct 2020

Recovered COVID-19 patients exhibit cognitive deficits

Researchers in the UK and the United States have reported concerning findings showing that patients who had recovered from coronavirus disease 2019 (COVID-19) exhibited significant cognitive deficits.

22 Oct 2020

New model could help identify people at risk for long COVID

Researchers in the UK, United States, and Sweden have presented new findings that could help identify individuals at risk of "long COVID" – a protracted course of coronavirus disease 2019 (COVID-19) symptoms last for more than 28 days.

22 Oct 2020

Aspirin use associated with reduced mortality risk in hospitalized COVID-19 patients

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine.

22 Oct 2020

Study may pave way for more effective treatment for Hepatitis C

Virologists at Institut national de la recherche scientifique (INRS) have identified a critical role played by a cellular protein in the progression of Hepatitis C virus infection, paving the way for more effective treatment.

22 Oct 2020

Study: Antiretroviral therapy fails to restore age-appropriate epigenetic patterns

Untreated HIV infection is linked with epigenetic changes that suggest rapid aging. A new study by UCLA researchers shows that antiretroviral therapy given over two years was unable to completely restore age-appropriate epigenetic patterns, leaving patients more susceptible to aging-related illnesses.

22 Oct 2020

Study reveals factors that account for reduced death rates from COVID-19

Fewer New Yorkers are dying from the coronavirus than health experts had anticipated, a new study shows. Regional death rates have dropped from the highs seen at the start of the outbreak, partially due to a shift in the population contracting the disease toward those who are more resilient.

22 Oct 2020

COVID-19 patient's immune response may underlie the effects on the nervous system

It is probably the immune response to, rather than the virus in itself, that causes sudden confusion and other symptoms from the nervous system in some patients with COVID-19. This is shown by a study of cases involving six Swedish patients, now published in the journal Neurology.

22 Oct 2020

Disease/Infection News

Vitamin C and COVID-19: A Review

Seropositivity to SARS-CoV-2 among asymptomatic blood donors in New York

Biomimetic virus-like particles for safer positive controls in SARS-CoV-2 detection

Study raises new questions about viral load in asymptomatic children with COVID-19

Meaning in life and self-control protect against stress during COVID-19 pandemic

Navy researchers evaluate commercial UV sources for viral disinfection to combat COVID-19

Nutritional status may impact susceptibility to COVID-19, study says

Anxiety and stress caused by COVID-19 associated with body image issues

Initial lockdown in France substantially curbed COVID-19, but many remain susceptible to the virus

WHO and Wikimedia Foundation expand public's access to most reliable information about COVID-19

DNA vaccine-induced antibodies neutralize SARS-CoV-2

$2 million NCI SeroNet grant aims to increase diversity in COVID-19 immunology research

First antiviral treatment for COVID-19 receives FDA approval

Recovered COVID-19 patients exhibit cognitive deficits

New model could help identify people at risk for long COVID

Aspirin use associated with reduced mortality risk in hospitalized COVID-19 patients

Study may pave way for more effective treatment for Hepatitis C

Study: Antiretroviral therapy fails to restore age-appropriate epigenetic patterns

Study reveals factors that account for reduced death rates from COVID-19

COVID-19 patient's immune response may underlie the effects on the nervous system

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News